Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

As the life sciences industry grapples with the demands of AI and the need to integrate real-world evidence into increasingly complex pipelines, the FAIR data principles — Findable, Accessible, ...

We stand at an extraordinary crossroads in medicine. This year, a young patient at Children's Hospital of Philadelphia received a treatment that would have been pure science fiction just decades ago — ...

Protecting patients and ensuring the reliability of trial outcomes depends on the consistent collection and monitoring of safety data. A well-structured safety database not only enables the ...

EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants. DENVER, Colo., Aug. 25, 2025 – PCM Trials, along ...

On this week's Business Of Biotech episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical trials during ambulance rides to the ...

Decades of technological innovation and scientific advances have revolutionized the treatment paradigm for many conditions that have long eluded conventional therapies. Advanced viral vector-based ...

Vaccines that use protein subunits or recombinant vectors are now the most common types of vaccines in development for infectious diseases and cancer, as they are relatively easy to produce and can be ...

On this week's episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with his sister Natasa Cmiljanovic, Ph.D. (and COO at Swiss ...

This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs expert Daniela Drago, Partner, NDA Partners, about how ...

Oncolytic viruses (OVs) are natural or recombinant attenuated versions of common viruses that do not cause disease but instead infect tumor cells preferentially over healthy cells. The virus ...